230 related articles for article (PubMed ID: 21666724)
1. Identification and functional analysis of 9p24 amplified genes in human breast cancer.
Wu J; Liu S; Liu G; Dombkowski A; Abrams J; Martin-Trevino R; Wicha MS; Ethier SP; Yang ZQ
Oncogene; 2012 Jan; 31(3):333-41. PubMed ID: 21666724
[TBL] [Abstract][Full Text] [Related]
2. Genomic amplification and oncogenic properties of the GASC1 histone demethylase gene in breast cancer.
Liu G; Bollig-Fischer A; Kreike B; van de Vijver MJ; Abrams J; Ethier SP; Yang ZQ
Oncogene; 2009 Dec; 28(50):4491-500. PubMed ID: 19784073
[TBL] [Abstract][Full Text] [Related]
3. Identification of a novel gene, GASC1, within an amplicon at 9p23-24 frequently detected in esophageal cancer cell lines.
Yang ZQ; Imoto I; Fukuda Y; Pimkhaokham A; Shimada Y; Imamura M; Sugano S; Nakamura Y; Inazawa J
Cancer Res; 2000 Sep; 60(17):4735-9. PubMed ID: 10987278
[TBL] [Abstract][Full Text] [Related]
4. Cortactin modulates RhoA activation and expression of Cip/Kip cyclin-dependent kinase inhibitors to promote cell cycle progression in 11q13-amplified head and neck squamous cell carcinoma cells.
Croucher DR; Rickwood D; Tactacan CM; Musgrove EA; Daly RJ
Mol Cell Biol; 2010 Nov; 30(21):5057-70. PubMed ID: 20805359
[TBL] [Abstract][Full Text] [Related]
5. A novel amplicon at 9p23 - 24 in squamous cell carcinoma of the esophagus that lies proximal to GASC1 and harbors NFIB.
Yang ZQ; Imoto I; Pimkhaokham A; Shimada Y; Sasaki K; Oka M; Inazawa J
Jpn J Cancer Res; 2001 Apr; 92(4):423-8. PubMed ID: 11346465
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide identification of genes with amplification and/or fusion in small cell lung cancer.
Iwakawa R; Takenaka M; Kohno T; Shimada Y; Totoki Y; Shibata T; Tsuta K; Nishikawa R; Noguchi M; Sato-Otsubo A; Ogawa S; Yokota J
Genes Chromosomes Cancer; 2013 Sep; 52(9):802-16. PubMed ID: 23716474
[TBL] [Abstract][Full Text] [Related]
7. Reexpression of hSNF5 in malignant rhabdoid tumor cell lines causes cell cycle arrest through a p21(CIP1/WAF1)-dependent mechanism.
Kuwahara Y; Charboneau A; Knudsen ES; Weissman BE
Cancer Res; 2010 Mar; 70(5):1854-65. PubMed ID: 20179200
[TBL] [Abstract][Full Text] [Related]
8. Molecular analysis of the INK4A and INK4B gene loci in human breast cancer cell lines and primary carcinomas.
Bisogna M; Calvano JE; Ho GH; Orlow I; Cordón-Cardó C; Borgen PI; Van Zee KJ
Cancer Genet Cytogenet; 2001 Mar; 125(2):131-8. PubMed ID: 11369056
[TBL] [Abstract][Full Text] [Related]
9. Expression of p27, p21(WAF/Cip1), and p16(INK4a) in normal oral epithelium, oral squamous papilloma, and oral squamous cell carcinoma.
Queiroz AB; Focchi G; Dobo C; Gomes TS; Ribeiro DA; Oshima CT
Anticancer Res; 2010 Jul; 30(7):2799-803. PubMed ID: 20683015
[TBL] [Abstract][Full Text] [Related]
10. Histone Demethylase GASC1 Inhibitor Targeted GASC1 Gene to Inhibit the Malignant Transformation of Esophageal Cancer through the NOTCH-MAPK Signaling Pathway.
Li Q; Qu B; Shen H; Deng H; Sun L
Ann Clin Lab Sci; 2022 Mar; 52(2):240-248. PubMed ID: 35414503
[TBL] [Abstract][Full Text] [Related]
11. The oncogenic role of GASC1 in chemically induced mouse skin cancer.
Ozaki Y; Fujiwara K; Ikeda M; Ozaki T; Terui T; Soma M; Inazawa J; Nagase H
Mamm Genome; 2015 Dec; 26(11-12):591-7. PubMed ID: 26248577
[TBL] [Abstract][Full Text] [Related]
12. Stat6 cooperates with Sp1 in controlling breast cancer cell proliferation by modulating the expression of p21(Cip1/WAF1) and p27 (Kip1).
Wei M; Liu B; Gu Q; Su L; Yu Y; Zhu Z
Cell Oncol (Dordr); 2013 Feb; 36(1):79-93. PubMed ID: 23184467
[TBL] [Abstract][Full Text] [Related]
13. Protection against chemotherapy-induced cytotoxicity by cyclin-dependent kinase inhibitors (CKI) in CKI-responsive cells compared with CKI-unresponsive cells.
Schmidt M; Fan Z
Oncogene; 2001 Sep; 20(43):6164-71. PubMed ID: 11593424
[TBL] [Abstract][Full Text] [Related]
14. Transforming function of the LSM1 oncogene in human breast cancers with the 8p11-12 amplicon.
Streicher KL; Yang ZQ; Draghici S; Ethier SP
Oncogene; 2007 Mar; 26(14):2104-14. PubMed ID: 17001308
[TBL] [Abstract][Full Text] [Related]
15. Cooperative epigenetic modulation by cancer amplicon genes.
Rui L; Emre NC; Kruhlak MJ; Chung HJ; Steidl C; Slack G; Wright GW; Lenz G; Ngo VN; Shaffer AL; Xu W; Zhao H; Yang Y; Lamy L; Davis RE; Xiao W; Powell J; Maloney D; Thomas CJ; Möller P; Rosenwald A; Ott G; Muller-Hermelink HK; Savage K; Connors JM; Rimsza LM; Campo E; Jaffe ES; Delabie J; Smeland EB; Weisenburger DD; Chan WC; Gascoyne RD; Levens D; Staudt LM
Cancer Cell; 2010 Dec; 18(6):590-605. PubMed ID: 21156283
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of a 19q12 amplicon in esophageal adenocarcinomas reveals cyclin E as the best candidate gene for this amplicon.
Lin L; Prescott MS; Zhu Z; Singh P; Chun SY; Kuick RD; Hanash SM; Orringer MB; Glover TW; Beer DG
Cancer Res; 2000 Dec; 60(24):7021-7. PubMed ID: 11156406
[TBL] [Abstract][Full Text] [Related]
17. KAT6A, a chromatin modifier from the 8p11-p12 amplicon is a candidate oncogene in luminal breast cancer.
Turner-Ivey B; Guest ST; Irish JC; Kappler CS; Garrett-Mayer E; Wilson RC; Ethier SP
Neoplasia; 2014 Aug; 16(8):644-55. PubMed ID: 25220592
[TBL] [Abstract][Full Text] [Related]
18. Multifaceted regulation of cell cycle progression by estrogen: regulation of Cdk inhibitors and Cdc25A independent of cyclin D1-Cdk4 function.
Foster JS; Henley DC; Bukovsky A; Seth P; Wimalasena J
Mol Cell Biol; 2001 Feb; 21(3):794-810. PubMed ID: 11154267
[TBL] [Abstract][Full Text] [Related]
19. Gene delivery of cyclin-dependent kinase inhibitors p21Waf1 and p27Kip1 suppresses proliferation of MCF-7 breast cancer cells in vitro.
Jiang D; Wang X; Liu X; Li F
Breast Cancer; 2014 Sep; 21(5):614-23. PubMed ID: 23338153
[TBL] [Abstract][Full Text] [Related]
20. Transforming properties of 8p11-12 amplified genes in human breast cancer.
Yang ZQ; Liu G; Bollig-Fischer A; Giroux CN; Ethier SP
Cancer Res; 2010 Nov; 70(21):8487-97. PubMed ID: 20940404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
